Since FTY720 is a functional inhibitor of multiple S1P receptors, further studies using selective receptor antagonists are required to clarify whether the expansion of the CD4+ T cells and CD4+ pDCs in the bone marrow during sepsis occurs through the same S1P signaling pathway. The gene discussed is CD4; the disease is Sepsis.